Managed care
Southern California Permanente Medical Group
Southern California Permanente Medical Group was paid $35.56M by Medicaid between Jan 2018 and Dec 2024, across 370 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 24% of everything it billed.
33Billing provider infoSOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP
PANORAMA CITY, CA 91402
PANORAMA CITY, CA 91402
33aNPI1407888928assigned 07/07/2006
33bProvider typeHealth Maintenance Organization
28Total paid$35.56M
24GClaims1,355,197
24DCodes billed370
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Health Maintenance Organization providers in California
Rank by total paid#6 of 151
Median peer was paid$59K
This provider vs. median602×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAVIDOFF, RAMIN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 261,182 | $171K | |
| 2019 | 176,895 | $469K | |
| 2020 | 109,073 | $2.42M | |
| 2021 | 153,084 | $4.84M | |
| 2022 | 163,937 | $5.75M | |
| 2023 | 219,137 | $8.95M | |
| 2024incomplete | 271,889 | $12.96M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 116,685 | 114,392 | $8.61M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 44,573 | 44,210 | $4.70M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.5% | 144,979 | 140,591 | $2.29M |
| 91320 | 3.6% | 7,612 | 7,610 | $1.28M | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 3.2% | 24,005 | 23,621 | $1.14M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.1% | 7,071 | 7,015 | $1.11M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.6% | 21,652 | 19,087 | $935K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.1% | 29,624 | 18,946 | $743K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.0% | 4,481 | 3,356 | $713K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.7% | 96,249 | 95,945 | $608K |
| 90662 | 1.5% | 4,665 | 4,665 | $520K | |
| 90480 | 1.4% | 9,344 | 9,330 | $487K |
358 more codes
| 67028 | Intravitreal injection of a pharmacologic agent | 1.3% | 2,158 | $453K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 32,190 | $408K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.1% | 15,019 | $381K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.1% | 1,378 | $378K |
| 92015 | Determination of refractive state | 1.0% | 43,591 | $366K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.0% | 3,497 | $361K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 39,950 | $341K |
| 77080 | <1% | 11,172 | $313K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 4,933 | $304K |
| 11721 | <1% | 3,129 | $291K | |
| 92002 | <1% | 8,680 | $272K | |
| 20610 | <1% | 2,660 | $249K | |
| 99441 | <1% | 11,075 | $243K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,767 | $231K |
| 93971 | <1% | 2,408 | $227K | |
| 93970 | <1% | 1,043 | $216K | |
| 0002A | <1% | 4,996 | $197K | |
| 99283 | Emergency room visit (moderate) | <1% | 5,596 | $196K |
| 0001A | <1% | 5,022 | $195K | |
| 73562 | <1% | 10,077 | $177K | |
| 71045 | Radiologic examination, chest; single view | <1% | 25,598 | $174K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 21,079 | $162K |
| 90674 | <1% | 9,824 | $156K | |
| 73564 | <1% | 4,385 | $142K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 1,417 | $140K |
| 73030 | <1% | 8,204 | $139K | |
| 0064A | <1% | 3,097 | $127K | |
| 99223 | Prolong inpt eval add15 m | <1% | 1,111 | $127K |
| 73630 | <1% | 13,281 | $119K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,981 | $111K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 2,815 | $109K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 946 | $108K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 5,051 | $104K |
| 0012A | <1% | 2,646 | $102K | |
| 90686 | <1% | 31,466 | $97K | |
| 92557 | <1% | 1,747 | $97K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 7,203 | $95K |
| 76830 | Ultrasound, transvaginal | <1% | 6,765 | $94K |
| 0011A | <1% | 2,541 | $94K | |
| 0124A | <1% | 2,645 | $91K | |
| J0178 | Injection, aflibercept, 1 mg | <1% | 16 | $88K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 7,690 | $87K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 5,553 | $81K |
| 73610 | <1% | 8,238 | $73K | |
| 11056 | <1% | 434 | $73K | |
| 72100 | <1% | 3,940 | $72K | |
| 0004A | <1% | 1,725 | $70K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,656 | $67K |
| 93268 | <1% | 183 | $67K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 4,758 | $67K |
| 99442 | <1% | 1,296 | $65K | |
| 92134 | <1% | 2,662 | $65K | |
| 99443 | <1% | 627 | $61K | |
| 0134A | <1% | 1,674 | $61K | |
| 73130 | <1% | 5,330 | $60K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,459 | $60K |
| 76770 | <1% | 2,126 | $58K | |
| 0054A | <1% | 1,372 | $58K | |
| 73110 | <1% | 4,823 | $57K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 2,733 | $56K |
| 92083 | <1% | 1,297 | $55K | |
| 90734 | <1% | 2,794 | $55K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 8,218 | $55K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 472 | $55K |
| 97597 | <1% | 392 | $52K | |
| 92567 | <1% | 2,918 | $51K | |
| 97161 | <1% | 862 | $51K | |
| J7999 | Compounded drug, not otherwise classified | <1% | 760 | $51K |
| 86360 | <1% | 1,081 | $50K | |
| 90651 | <1% | 3,980 | $50K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,653 | $48K |
| 93880 | <1% | 176 | $48K | |
| 97162 | <1% | 497 | $47K | |
| 93296 | <1% | 682 | $46K | |
| J0177 | Injection, aflibercept hd, 1 mg | <1% | 18 | $45K |
| 94726 | <1% | 421 | $45K | |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | <1% | 53 | $44K |
| 90750 | <1% | 458 | $43K | |
| 73560 | <1% | 1,976 | $42K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 125 | $42K |
| 92133 | <1% | 1,446 | $42K | |
| 86359 | <1% | 1,081 | $41K | |
| 0071A | <1% | 1,010 | $41K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 4,334 | $41K |
| 92551 | <1% | 24,155 | $40K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 327 | $40K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 764 | $39K |
| 93294 | <1% | 445 | $38K | |
| 73502 | <1% | 1,181 | $36K | |
| 83880 | <1% | 741 | $36K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 425 | $36K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 760 | $34K |
| 72170 | <1% | 1,592 | $33K | |
| 82565 | <1% | 9,450 | $33K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 380 | $33K |
| 80051 | <1% | 8,009 | $32K | |
| 0072A | <1% | 781 | $31K | |
| 90837 | Psychotherapy session, about an hour | <1% | 1,229 | $29K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 1,284 | $27K |
| 76642 | <1% | 950 | $27K | |
| 99220 | <1% | 144 | $27K | |
| 90670 | <1% | 4,072 | $26K | |
| 77065 | Tomosynthesis, mammo | <1% | 612 | $25K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 18,586 | $24K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 915 | $24K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 9,965 | $24K |
| 84460 | <1% | 6,942 | $21K | |
| 73140 | <1% | 3,255 | $21K | |
| 76536 | <1% | 1,230 | $20K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,748 | $19K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 852 | $19K |
| 90656 | <1% | 3,678 | $19K | |
| 94729 | <1% | 185 | $19K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 21 | $19K |
| 84075 | <1% | 5,719 | $19K | |
| 82247 | <1% | 6,170 | $18K | |
| 83921 | <1% | 525 | $17K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,236 | $17K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,397 | $17K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 14 | $16K |
| 95117 | <1% | 2,667 | $16K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,366 | $16K |
| 72040 | <1% | 1,007 | $15K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 183 | $15K |
| 17110 | <1% | 253 | $15K | |
| 0031A | <1% | 376 | $15K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 50 | $15K |
| 84450 | <1% | 3,496 | $15K | |
| 82947 | <1% | 6,518 | $15K | |
| 86141 | <1% | 1,635 | $14K | |
| 73080 | <1% | 1,687 | $14K | |
| 90677 | <1% | 1,039 | $14K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 28 | $14K |
| 84520 | <1% | 5,894 | $14K | |
| 81003 | <1% | 11,324 | $13K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,133 | $13K |
| 73590 | <1% | 1,210 | $13K | |
| 90679 | <1% | 69 | $12K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,050 | $12K |
| 90710 | <1% | 560 | $12K | |
| 85610 | <1% | 5,469 | $12K | |
| 71101 | <1% | 450 | $12K | |
| 11102 | <1% | 65 | $11K | |
| 69210 | <1% | 134 | $11K | |
| 74018 | <1% | 2,078 | $11K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 30,112 | $11K |
| 93280 | <1% | 43 | $11K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 63 | $10K |
| 83690 | <1% | 3,230 | $10K | |
| 99219 | <1% | 101 | $10K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 371 | $10K |
| 0154A | <1% | 262 | $10K | |
| 81329 | <1% | 463 | $10K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 174 | $10K |
| 76641 | <1% | 560 | $10K | |
| 88342 | <1% | 255 | $9K | |
| 99225 | <1% | 92 | $9K | |
| 93922 | <1% | 57 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,150 | $8K |
| 85027 | <1% | 10,776 | $7K | |
| 83735 | <1% | 1,079 | $7K | |
| 96900 | <1% | 212 | $7K | |
| 73501 | <1% | 207 | $7K | |
| 73100 | <1% | 600 | $7K | |
| 82310 | <1% | 1,258 | $7K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 28 | $7K |
| 84484 | <1% | 922 | $7K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 7,126 | $7K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 2,463 | $7K |
| 84702 | <1% | 2,267 | $6K | |
| 99205 | Prolong outpt/office vis | <1% | 42 | $6K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 730 | $6K |
| 88304 | <1% | 981 | $6K | |
| 97165 | <1% | 183 | $6K | |
| 94010 | <1% | 114 | $6K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,343 | $6K |
| 90648 | <1% | 5,202 | $6K | |
| 90723 | <1% | 2,749 | $6K | |
| 99234 | <1% | 83 | $6K | |
| 0074A | <1% | 145 | $5K | |
| 90633 | <1% | 2,530 | $5K | |
| 73120 | <1% | 381 | $5K | |
| J1750 | Injection, iron dextran, 50 mg | <1% | 15 | $5K |
| 92136 | <1% | 88 | $5K | |
| 73522 | <1% | 61 | $5K | |
| 72050 | <1% | 220 | $4K | |
| 11055 | <1% | 25 | $4K | |
| 91319 | <1% | 289 | $4K | |
| 92235 | <1% | 74 | $4K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 102 | $4K |
| 93016 | <1% | 93 | $4K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 14 | $4K |
| 99173 | <1% | 16,943 | $4K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 223 | $4K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 337 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,632 | $3K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 65 | $3K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 394 | $3K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 587 | $3K |
| 91200 | <1% | 90 | $3K | |
| 73660 | <1% | 528 | $3K | |
| 85652 | <1% | 2,967 | $3K | |
| 90715 | <1% | 779 | $3K | |
| 82105 | <1% | 654 | $3K | |
| 99217 | <1% | 28 | $3K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 130 | $3K |
| 90672 | <1% | 875 | $3K | |
| 81002 | <1% | 4,154 | $3K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 13 | $3K |
| 0052A | <1% | 67 | $3K | |
| 77066 | Tomosynthesis, mammo | <1% | 90 | $3K |
| 93018 | <1% | 93 | $3K | |
| 99177 | <1% | 2,809 | $3K | |
| 73552 | <1% | 55 | $2K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 72 | $2K |
| 94060 | <1% | 26 | $2K | |
| 74019 | <1% | 101 | $2K | |
| 0112A | <1% | 55 | $2K | |
| 72070 | <1% | 126 | $2K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 43 | $2K |
| 90696 | <1% | 547 | $2K | |
| 73090 | <1% | 411 | $2K | |
| 0081A | <1% | 50 | $2K | |
| 98968 | <1% | 98 | $2K | |
| 90716 | <1% | 291 | $2K | |
| 0111A | <1% | 43 | $2K | |
| 0082A | <1% | 42 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 49 | $2K |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 136 | $2K |
| 87338 | <1% | 807 | $1K | |
| 93288 | <1% | 12 | $1K | |
| 97116 | <1% | 38 | $1K | |
| 90681 | <1% | 631 | $1K | |
| 91318 | <1% | 202 | $1K | |
| 0013A | <1% | 27 | $1K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 86 | $1K |
| 90660 | <1% | 188 | $1K | |
| 90707 | <1% | 347 | $1K | |
| 93295 | <1% | 13 | $822.75 | |
| 51798 | <1% | 39 | $816.00 | |
| 90700 | <1% | 467 | $795.00 | |
| 99307 | <1% | 368 | $781.08 | |
| 76881 | <1% | 24 | $770.00 | |
| 81206 | <1% | 12 | $740.00 | |
| 0003A | <1% | 17 | $722.28 | |
| 0083A | <1% | 38 | $695.06 | |
| 90381 | <1% | 47 | $653.00 | |
| 87799 | <1% | 26 | $611.52 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 120 | $605.21 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 465 | $599.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 960 | $525.00 |
| 0051A | <1% | 12 | $483.78 | |
| 0053A | <1% | 13 | $480.00 | |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | <1% | 78 | $468.00 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 14 | $450.00 |
| 92504 | <1% | 39 | $435.98 | |
| 99051 | <1% | 34,695 | $430.00 | |
| 64450 | <1% | 14 | $424.00 | |
| 73060 | <1% | 56 | $392.31 | |
| 82950 | <1% | 522 | $382.56 | |
| 73000 | <1% | 29 | $350.00 | |
| 90655 | <1% | 262 | $345.00 | |
| 99201 | <1% | 510 | $296.35 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 163 | $289.26 |
| 82962 | <1% | 54 | $273.28 | |
| 99417 | Prolong home eval add 15m | <1% | 13 | $238.38 |
| 99188 | <1% | 105 | $176.00 | |
| 72081 | <1% | 39 | $162.55 | |
| 90756 | <1% | 2,050 | $156.96 | |
| 82248 | <1% | 52 | $139.92 | |
| 88141 | <1% | 18 | $130.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 102 | $115.01 |
| 85014 | <1% | 634 | $102.00 | |
| 76813 | <1% | 60 | $98.05 | |
| 87210 | <1% | 1,609 | $95.82 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 146 | $95.55 |
| 90688 | <1% | 1,828 | $89.20 | |
| 72080 | <1% | 12 | $75.00 | |
| 76870 | <1% | 31 | $70.37 | |
| 86580 | <1% | 37 | $60.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 147 | $55.16 |
| 74022 | <1% | 31 | $46.83 | |
| 85018 | <1% | 103 | $42.00 | |
| 82985 | <1% | 13 | $37.80 | |
| 88720 | <1% | 14 | $30.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 15 | $21.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 103 | $19.38 |
| 90685 | <1% | 37 | $12.83 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 12 | $9.94 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 24 | $9.80 |
| 82570 | <1% | 490 | $8.44 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 819 | $7.01 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 27 | $2.73 |
| 81025 | <1% | 162 | $2.52 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 45 | $1.52 |
| G9920 | Screening performed and negative | <1% | 4,549 | $0.02 |
| 1036F | 0% | 22,769 | $0.00 | |
| 83550 | 0% | 25 | $0.00 | |
| 82040 | 0% | 35 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 28 | $0.00 |
| 95125 | 0% | 61 | $0.00 | |
| 82550 | 0% | 190 | $0.00 | |
| 96040 | 0% | 39 | $0.00 | |
| 99024 | 0% | 700 | $0.00 | |
| 64566 | 0% | 74 | $0.00 | |
| 85379 | 0% | 165 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 121 | $0.00 |
| D1206 | Topical application of fluoride varnish | 0% | 14 | $0.00 |
| 3044F | 0% | 1,108 | $0.00 | |
| 86140 | 0% | 1,205 | $0.00 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 0% | 27 | $0.00 |
| 87088 | 0% | 258 | $0.00 | |
| 82043 | 0% | 315 | $0.00 | |
| 85730 | 0% | 675 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 403 | $0.00 |
| 92523 | 0% | 82 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 41 | $0.00 |
| 92587 | 0% | 27 | $0.00 | |
| 99460 | 0% | 12 | $0.00 | |
| 82728 | 0% | 47 | $0.00 | |
| 84132 | 0% | 82 | $0.00 | |
| 92227 | 0% | 150 | $0.00 | |
| 87081 | 0% | 27 | $0.00 | |
| 36000 | 0% | 14 | $0.00 | |
| 96111 | 0% | 14 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 18 | $0.00 |
| 82607 | 0% | 55 | $0.00 | |
| 3052F | 0% | 26 | $0.00 | |
| 86308 | 0% | 14 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 26 | $0.00 |
| 84153 | 0% | 15 | $0.00 | |
| 95012 | 0% | 12 | $0.00 | |
| 83721 | 0% | 14 | $0.00 | |
| 90661 | 0% | 1,030 | $0.00 | |
| 85046 | 0% | 74 | $0.00 | |
| 82274 | 0% | 179 | $0.00 | |
| 84156 | 0% | 465 | $0.00 | |
| 90658 | 0% | 116 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 139 | $0.00 |
| 80061 | Lipid panel | 0% | 472 | $0.00 |
| 73070 | 0% | 27 | $0.00 | |
| 83540 | 0% | 40 | $0.00 | |
| 84550 | 0% | 16 | $0.00 | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 0% | 40 | $0.00 |
| 87186 | 0% | 115 | $0.00 | |
| 3046F | 0% | 16 | $0.00 | |
| 84439 | 0% | 120 | $0.00 | |
| 84100 | 0% | 32 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 24 | $0.00 |
| 3051F | 0% | 29 | $0.00 | |
| 01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery | 0% | 51 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 18 | $0.00 |
| G0127 | Trimming of dystrophic nails, any number | 0% | 12 | $0.00 |
| 77072 | 0% | 18 | $0.00 | |
| 84295 | 0% | 12 | $0.00 | |
| 90461 | 0% | 12 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 16 | $0.00 |
| 92579 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIDOFF, RAMIN (EXECUTIVE MEDICAL DIRECTOR)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.